Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial - Kelley, R K; Ueno, M; Yoo, C; KEYNOTE-966 Investigators (Lancet, 2023)
(10391):